0001144204-14-010654.txt : 20140219 0001144204-14-010654.hdr.sgml : 20140219 20140219173336 ACCESSION NUMBER: 0001144204-14-010654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140214 FILED AS OF DATE: 20140219 DATE AS OF CHANGE: 20140219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QUILTY EDWARD J CENTRAL INDEX KEY: 0001045507 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 14626934 MAIL ADDRESS: STREET 1: DERMA SCIENCES, INC. STREET 2: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 v369186_4.xml OWNERSHIP DOCUMENT X0306 4 2014-02-14 0 0000892160 DERMA SCIENCES, INC. DSCI 0001045507 QUILTY EDWARD J DERMA SCIENCES, INC. 214 CARNEGIE CENTER, SUITE 300 PRINCETON NJ 08540 1 1 0 0 President & CEO Common Stock 2014-02-14 4 A 0 7900 0 A 159793 D Common Stock 2014-02-14 4 M 0 6250 12.40 A 166043 D Common Stock 2014-02-14 4 F 0 5871 13.20 D 160172 D Stock Option (right to buy) 11.97 2014-02-14 4 A 0 26300 0 A 2014-02-14 2023-02-13 Common Stock 26300 26300 D Stock Option (right to buy) 13.39 2014-02-14 4 A 0 36000 0 A 2014-02-14 2024-02-14 Common Stock 36000 36000 D Stock Option (right to buy) 12.40 2014-02-14 4 M 0 6250 0 D 2004-02-24 2014-02-24 Common Stock 6250 0 D The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 7,900 restricted stock units. Shares delivered in connection with the cashless exercise of 6,250 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $12.40, as reported herein. The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 26,300 options. The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date and will vest as to an additional 25% on February 14 of 2015, 2016 and 2017. The options, granted pursuant to the issuer's stock option plan, vested as to 25% on the grant date, and vested as to an additional 25% on February 24 of 2005, 2006 and 2007. The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash. /s/ Edward J. Quilty 2014-02-19